Biomarkers of lung injury in critical care medicine: Past, present, and future

Immunological Investigations

Volumn 42, Issue 3, 2013, Pages 247-261

  Tunceroglu, Huseyin ^a   Shah, Anjan ^a   Porhomayon, Jahan ^a   Nader, Nader D ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Acute Lung Injury; Cytokine; Inflammatory Biomarkers.; Respiratory Distress

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANTIBIOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CLARA CELL PROTEIN; CLARA CELL PROTEIN 16; CYTOCHROME B5; CYTOKERATIN 17; GLYCOPROTEIN; GLYCOPROTEIN KL 6; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROCALCITONIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN D; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; BASEMENT MEMBRANE; BLOOD OXYGENATION; CAPILLARY WALL; CLINICAL FEATURE; EARLY DIAGNOSIS; HUMAN; INFLAMMATION; INTENSIVE CARE; LUNG FIBROSIS; LUNG GAS EXCHANGE; LUNG LAVAGE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY;

ACUTE LUNG INJURY; ANIMALS; BIOLOGICAL MARKERS; CRITICAL CARE; CYTOKINES; HUMANS; INFLAMMATION; LUNG; MICE;

EID: 84874876718     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2012.750667     Document Type: Review

References (60)

1. Bajaj, M. S., Tricomi, S. M. 1999 Plasma levels of the three endothelial-specific proteins von willebrand factor, tissue factor pathway inhibitor, and thrombomodulin do not predict the development of acute respiratory distress syndrome. Intens. Care Med. 2511 1259-1266.
2. Bajwa, E. K., Khan, U. A., Januzzi, J. L., Gong, M. N., Thompson, B. T., Christiani, D. C. 2009 Plasma c-reactive protein levels are associated with improved outcome in ards. Chest 1362 471-480.
3. Barnett, N., Ware, L. B. 2011 Biomarkers in acute lung injury-marking forward progress. Crit. Care Clin. 273 661-683.
4. Bernard, G. R., Artigas, A., Brigham, K. L., Carlet, J., Falke, K., Hudson, L., Lamy, M.,Legall, J. R., Morris, A., Spragg, R. 1994 Report of the American-European Consensus Conference on Acute Respiratory Distress Syndrome Definitions,mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J. Crit. Care 91 72-81.
5. Biomarkers Definitions Working Group 2001 Biomarkers and surrogate endpoints Preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 693 89-95.
6. Bonniaud, P., Margetts, P. J., Ask, K., Flanders, K., Gauldie, J., Kolb, M. 2005 Tgf-beta and smad3 signaling link inflammation to chronic fibrogenesis. J. Immunol. 1758 5390-5395.
7. Broeckaert, F., Bernard, A. 2000 Clara cell secretory protein cc16 Characteristics and perspectives as lung peripheral biomarker. Clin. Exp. Allergy 304 469-475.
8. Calfee, C. S., Eisner, M. D., Parsons, P. E., Thompson, B. T., Conner, E. R., Jr., Matthay,M. A., Ware, L. B. 2009 Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury. Intens. Care Med. 352 248-257.
9. Calfee, C. S., Ware, L. B., Eisner, M. D., Parsons, P. E., Thompson, B. T., Wickersham, N.,and Matthay, M. A. 2008 Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 6312 1083-1089.
10. Cross, L. J., and Matthay, M. A. 2011 Biomarkers in acute lung injury Insights into the pathogenesis of acute lung injury. Crit. Care Clin. 272 355-377.
11. Dada, L. A., and Sznajder, J. I. 2007 Hypoxic inhibition of alveolar fluid reabsorption. Adv. Exp. Med. Biol. 618 159-168.
12. Determann, R. M., Millo, J. L., Waddy, S., Lutter, R., Garrard, C. S., Schultz, M. J. 2009 Plasma cc16 levels are associated with development of ali/ards in patients with ventilator-associated pneumonia A retrospective observational study. BMC Pulm. Med. 9 49.
13. Dos Santos, G., Kutuzov, M. A., Ridge, K. M. 2012 The inflammasome in lung diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 3038 L627-L633.
14. Durr, U. H., Waskell, L., Ramamoorthy, A. 2007 The cytochromes p450 and b5 and their reductases-promising targets for structural studies by advanced solid-state nmr spectroscopy. Biochim. Biophys. Acta 176812 3235-3259.
15. Eisner, M. D., Parsons, P., Matthay, M. A., Ware, L., Greene, K. 2003 "Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury." Thorax 5811 983-988.
16. Fan, J., Ye, R.D., Malik, A.B. 2001 Transcriptional mechanisms of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2815 L1037-1050.
17. Flori, H. R., Ware, L. B., Glidden, D., Matthay, M. A. 2003 Early elevation of plasma soluble intercellular adhesion molecule-1 in pediatric acute lung injury identifies patients at increased risk of death and prolonged mechanical ventilation. Pediatr. Crit. Care Med. 43 315-321.
18. Gallagher, D. C., Parikh, S. M., Balonov, K., Miller, A., Gautam, S., Talmor, D.,Sukhatme, V. P. 2008 Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock 296 656-661.
19. Ganter, M. T., Roux, J., Miyazawa, B., Howard, M., Frank, J. A., Su, G., Sheppard, D.,Violette, S. M., Weinreb, P. H., Horan, G. S., Matthay, M. A., Pittet, J. F. 2008 Interleukin-1beta causes acute lung injury via #v#5 and #v#6 integrin-dependent mechanisms. Circ. Res. 1027 804-812.
20. Gerlach, H., Toussaint, S. 2011 Sensitive, specific, predictive . . . Statistical basics How to use biomarkers. Crit. Care Clin. 272 215-227.
21. Greene, K. E., Wright, J. R., Steinberg, K. P., Ruzinski, J. T., Caldwell, E., Wong,W. B., Hull, W., Whitsett, J. A., Akino, T., Kuroki, Y., Nagae, H., Hudson,L. D., Martin, T. R. 1999 Serial changes in surfactant-associated proteins in lung and serum before and after onset of ards. Am. J. Respir. Crit. Care Med. 1606 1843-1850.
22. Howrylak, J. A., Dolinay, T., Lucht, L.,Wang, Z., Christiani, D. C., Sethi, J.M., Xing,E. P., Donahoe,M. P., Choi, A. M. 2009 Discovery of the gene signature for acute lung injury in patients with sepsis. Physiol. Genomics 372 133-139.
23. Idell, S. 2003 Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit. Care Med. 314 Suppl S213-220.
24. Ishizaka, A., Matsuda, T., Albertine, K. H., Koh, H., Tasaka, S., Hasegawa, N., Kohno, N.,Kotani, T., Morisaki, H., Takeda, J., Nakamura, M., Fang, X., Martin, T. R., Matthay,M. A., Hashimoto, S. 2004 Elevation of kl-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am. J. Physiol. Lung Cell. Mol. Physiol. 2866 L1088-1094.
25. Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F., Gauldie, J. 2001 Transient expression of il-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J. Clin. Invest. 10712 1529-1536.
26. Kropski, J. A., Fremont, R. D., Calfee, C. S., Ware, L. B. 2009 Clara cell protein cc16, a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury. Chest 1356 1440-1447.
27. Lesur, O., Langevin, S., Berthiaume, Y., Legare, M., Skrobik, Y., Bellemare, J. F., Levy,B., Fortier, Y., Lauzier, F., Bravo, G., Nickmilder, M., Rousseau, E., Bernard, A. 2006 Outcome value of clara cell protein in serum of patients with acute respiratory distress syndrome. Intens. Care Med. 328 1167-1174.
28. Lin, W. C., Lin, C. F., Chen, C. L., Chen, C. W., and Lin, Y. S. 2010 "Prediction of outcome in patients with acute respiratory distress syndrome by bronchoalveolar lavage inflammatory mediators." Exp. Biol. Med. Maywood 2351 57-65.
29. Mcclintock, D., Zhuo, H., Wickersham, N., Matthay, M. A., Ware, L. B. 2008 Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury. Crit. Care 122 R41.
30. Meduri, G. U., Headley, S., Kohler, G., Stentz, F., Tolley, E., Umberger, R., Leeper, K. 1995a Persistent elevation of inflammatory cytokines predicts a poor outcome in ards. Plasma il-1 beta and il-6 levels are consistent and efficient predictors of outcome over time. Chest 1074 1062-1073.
31. Meduri, G. U., Kohler, G., Headley, S., Tolley, E., Stentz, F., Postlethwaite, A. 1995b Inflammatory cytokines in the bal of patients with ards. Persistent elevation over time predicts poor outcome. Chest 1085 1303-1314.
32. Menoret, A., Kumar, S., Vella, A. T. 2012 Cytochrome b5 and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injury. PLoS One 77 e40184.
33. Moss, M., Ackerson, L., Gillespie, M. K., Moore, F. A., Moore, E. E., Parsons, P. E. 1995 Von willebrand factor antigen levels are not predictive for the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 1511 15-20.
34. Muller, W. A. 2009 "Mechanisms of transendothelial migration of leukocytes." Circ Res 1053 223-230.
35. Nader, N. D., Mcquiller, P. S., Raghavendran, K., Spengler, R. N., and Knight, P. R. 2007 The role of alveolar macrophages in the pathogenesis of aspiration pneumonitis. Immunol Invest. 364 457-471.
36. Park, W. Y., Goodman, R. B., Steinberg, K. P., Ruzinski, J. T., Radella, F., 2nd, Park,D. R., Pugin, J., Skerrett, S. J., Hudson, L. D., Martin, T. R. 2001 Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 16410 Pt 1 1896-1903.
37. Parsons, P. E., Eisner, M. D., Thompson, B. T., Matthay, M. A., Ancukiewicz, M.,Bernard, G. R., Wheeler, A. P. 2005a Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit. Care Med. 331 1-6; discussion 230-232.
38. Parsons, P. E., Matthay, M. A., Ware, L. B., Eisner, M. D. 2005b Elevated plasma levels of soluble tnf receptors are associated with morbidity and mortality in patients with acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2883 L426-431.
39. Prabhakaran, P., Ware, L. B., White, K. E., Cross, M. T., Matthay, M. A., Olman, M. A. 2003 Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2851 L20-28.
40. Pugin, J., Ricou, B., Steinberg, K. P., Suter, P. M., Martin, T. R. 1996 Proinflammatory activity in bronchoalveolar lavage fluids from patients with ards, a prominent role for interleukin-1. Am. J. Respir. Crit. Care Med. 1536 Pt 1 1850-1856.
41. Pugin, J., Verghese, G., Widmer, M. C., Matthay, M. A. 1999 "The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit. Care Med. 272 304-312.
42. Ranieri, V. M., Rubenfeld, G. D., Thompson, B. T., Ferguson, N. D., Caldwell, E., Fan, E.,Camporota, L., Slutsky, A. S. 2012 Acute respiratory distress syndrome The Berlin definition. JAMA 30723 2526-2533.
43. Rubenfeld, G. D., Caldwell, E., Peabody, E., Weaver, J., Martin, D. P., Neff, M., Stern,E. J., Hudson, L. D. 2005 Incidence and outcomes of acute lung injury. N. Engl. J. Med. 35316 1685-1693.
44. Rubenfeld, G. D., Herridge, M. S. 2007 Epidemiology and outcomes of acute lung injury. Chest 1312 554-562.
45. Schenkman, J. B., Jansson, I. 2003 The many roles of cytochrome b5. Pharmacol. Ther. 972 139-152.
46. Schnapp, L. M., Donohoe, S., Chen, J., Sunde, D. A., Kelly, P. M., Ruzinski, J., Martin, T.,Goodlett, D. R. 2006 Mining the acute respiratory distress syndrome proteome Identification of the insulin-like growth factor igf/igf-binding protein-3 pathway in acute lung injury. Am. J. Pathol. 1691 86-95.
47. Schottelius, A. J., Mayo, M. W., Sartor, R. B., Baldwin, A. S., Jr. 1999 Interleukin-10 signaling blocks inhibitor of kappab kinase activity and nuclear factor kappab DNA binding. J. Biol. Chem. 27445 31868-31874.
48. Stringer, K. A., Serkova, N. J., Karnovsky, A., Guire, K., Paine, R. 3rd, Standiford, T. J. 2011 Metabolic consequences of sepsis-induced acute lung injury revealed by plasma 1h-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am. J. Physiol. Lung Cell Mol. Physiol. 3001 L4-L11.
49. Tseng, J. S., Chan, M. C., Hsu, J. Y., Kuo, B. I., Wu, C. L. 2008 Procalcitonin is a valuable prognostic marker in ards caused by community-acquired pneumonia. Respirology 134 505-509.
50. Uchida, T., Shirasawa, M., Ware, L. B., Kojima, K., Hata, Y., Makita, K., Mednick, G.,Matthay, Z. A., Matthay, M. A. 2006 Receptor for advanced glycation end-products is a marker of type i cell injury in acute lung injury. Am. J. Respir. Crit. Care Med. 1739 1008-1015.
51. Van Meurs, M., Kumpers, P., Ligtenberg, J. J., Meertens, J. H., Molema, G., and Zijlstra,J. G. 2009 "Bench-to-bedside review Angiopoietin signalling in critical illness - A future target?" Crit. Care 132 207.
52. Wang, P., Wu, P., Siegel, M. I., Egan, R. W., Billah, M. M. 1995 Interleukin il-10 inhibits nuclear factor kappa b nf kappa b activation in human monocytes. Il-10 and il-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 27016 9558-9563.
53. Wang, Z., Beach, D., Su, L., Zhai, R., Christiani, D. C. 2008 A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ards. Am. J. Respir. Cell Mol. Biol. 386 724-732.
54. Ward, P. A. 1996 "Role of complement, chemokines, and regulatory cytokines in acute lung injury." Ann. N.Y. Acad. Sci. 796 104-112.
55. Ware, L. B. 2006 Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin. Respir. Crit. Care Med. 274 337-349.
56. Ware, L. B., Conner, E. R., Matthay, M. A. 2001 Von willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Crit. Care Med. 2912 2325-2331.
57. Ware, L. B., Kaner, R. J., Crystal, R. G., Schane, R., Trivedi, N. N., Mcauley, D., Matthay,M. A. 2005 Vegf levels in the alveolar compartment do not distinguish between ards and hydrostatic pulmonary oedema. Eur. Respir. J. 261 101-105.
58. Ware, L. B., Koyama, T., Billheimer, D. D., Wu, W., Bernard, G. R., Thompson, B. T.,Brower, R. G., Standiford, T. J., Martin, T. R., Matthay, M. A. 2010 Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 1372 288-296.
59. Wu, C. L., Lin, L. Y., Yang, J. S., Chan, M. C., Hsueh, C. M. 2009 Attenuation of lipopolysaccharide-induced acute lung injury by treatment with il-10. Respirology 144 511-521.
60. Zhang, Y., Lee, T. C., Guillemin, B., Yu, M. C., Rom, W. N. 1993 Enhanced il-1 beta and tumor necrosis factor-alpha release and messenger rna expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J. Immunol. 1509 4188-4196.